Potential Effect of Alendronate on Tooth Eruption and Molar Root Formation in Young Growing and Osteoprotic Albino Rats (A Histological and Histochemical Study) | ||||
| Al-Azhar Dental Journal for Girls | ||||
| Article 3, Volume 5, Issue 3, July 2018, Page 237-242 PDF (380.7 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/adjg.2018.17185 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Somaya Salwat1; Mona Farid2; Heba Hakam3 | ||||
| 1Demonstrator of Oral and Dental Biology, Faculty of Dental Medicine for Girls , Al- Azhar University. | ||||
| 2Professor and Head of Oral and Dental Biology Department, the Former Dean of Faculty of Dental Medicine for Girls, Al- Azhar University. | ||||
| 3Assistant Professor of Oral and Dental Biology, Faculty of Dental Medicine for Girls, Al- Cairo University. | ||||
| Abstract | ||||
| Aim: The aim of the present study to evaluate the potential effect of Sodium Alendronate on tooth eruption and root formation in young growing and osteoporotic albino rats . Materials and Methods Sixty newborn wister albino rats with their average weight 6 grams, each were used in the study. Rats were divided into 4 groups (groupI, groupII, group III &group IV) : GI negative control, GII positive control, GIII Alendronat treated group, GIV (alendronate + dexamethasone) then each group was divided into 3 subgroups according to the date of scarification at7,14,30 days. Rats were subjected to subcutaneous injection of sodium alendronate and dexamethasone in their dorsal back. The specimens were processed for histological and histochemical analysis. Results: alendronate prevented tooth eruption and root formation but dexamethasone caused resorption of bone over developing molar but didn’t affect molar eruption and root formation. Conclusion: sodium alendronate caused increase in bone formation and obstructed eruption pathway. Sodium alendronate prevented maturation of alveolar bone while dexamethasone caused destruction of alveolar bone but didn’t affect normal tooth eruption. | ||||
| Keywords | ||||
| Sodium alendronate; dexamethasone; tooth eruption; root formation | ||||
| References | ||||
|
1.
Marks SC Jr and Schroeder HE, Tooth eruption: theories and facts. Anat Rec 1996; 374–393 2. G. Sandgren, “GAPO syndrome: a new case,” American Journal of Medical Genetics 1995; 87–90 3.
Rhen T and Cidlowski JA. Anti inflammatory action of glucocorticoids--new mechanisms for old drugs. The New England journal of medicine 2005; 1711-23
4. Chrousos GP and Kino T. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Science’s STKE: signal transduction knowledge environment 2005; 48-66 5. Harris ST, Watts NB, Jackson RD et al. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med 1993; 557–567 6. Asikaran S. Bisphosphonates: an overview with special refer
ence to alendronate. Ann ClinBiochem, 2001; 608–23 7. Massa LF, Bradaschia-Correa V, Arana-Chavez VE Immunocytochemical study of amelogenin deposition during the early odontogenesis of molars in alendronate-treat
ed newborn rats. J Histochem Cytochem 2006; 713–725 8. Brown & Richard. Histologic Preparations: Common Problems and Their Solutions. College of American Pathologists, 2009; 95-101 9.
Carson, Freida L., and Christa Hladik. Histotechnology: A Self Instructional Text. 3
rd ed.: American Society of Clinical Pathologists, 2009; 162-165 10. Gary E. Wise, Robert L. Grier IV, Steven J. Lumpkin, Quiyang Zhang. Effects of Dexamethasone on Tooth Eruption in Rats: Differences in Incisor and Molar Eruption Clin. Anat. 2001; 204–209 11.
McClung M. Use of highly potent bisphosphonates in the treatment of osteoporosis. Curr Osteoporos 2003;116–122 12.
Maasalu K, Haviko T, Martson A. Treatment of children with osteogenesis imperfecta in Estonia. Acta Paediatr 2003; 452–455 13. van Beek ER, Cohen LH, Leroy IM, Ebetino FH, Löwik CWGM, Papapoulos SE. Differentiating the mechanisms of resorptive action of nitrogen containing bisphosphonates. Bone, 2003; 805–811 14. Grier RL & Wise GE. Inhibition of tooth eruption in the rat by a bisphosphonate. J Dent Res 1998; 8–15 15.
Marks SC Jr &Schroeder HE. Tooth eruption: theories and facts. Anat Rec 1996; 374–393 16.
Wise GE, Frazier-Bowers S, D’Souza RN. Cellular, molecular and genetic determinants of tooth eruption. Crit Rev Oral Biol Med 2002; 323–334 17. (105) Marks SC Jr. Pathogenesis of osteopetrosis in the IA rat: reduced bone resorption due to reduced osteoclast function. Am J Anat 1973; 165–189 | ||||
|
Statistics Article View: 235 PDF Download: 304 |
||||
